Mother Nutri (544623)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trailing profitability is visible through the P/E: at ₹182 Cr market cap and 28.09 P/E, implied net profit is around ₹6.48 Cr.
• ROCE of 23.74% is respectable and indicates meaningful return on capital employed.
• Listing on NSE/BSE provides regulatory disclosure obligations and exit liquidity.
• Small market cap of ₹182 Cr leaves room for future growth if the business delivers real numbers.

Concerns

• Latest quarter shows ₹0 Cr sales and ₹0 Cr net profit, with both sales and profit growth at 0.00%.
• Piotroski F-Score of 3/9 flags weak financial health.
• At P/E 28.09 and 0.00% dividend yield, valuation is demanding with no income cushion.
• Critical data is missing: book value, ROE, debt/equity, and promoter holding, making a Graham-style margin-of-safety calculation impossible.

AI Analysis

At first glance, Mother Nutri is exactly the kind of stock that tests my discipline. The market is asking ₹145 per share, ₹182 crore in total, and paying 28.09 times earnings. For that multiple, I expect a growing, profitable franchise. Instead, the figures show sales growth of 0.00% and profit growth of 0.00%, with the latest quarter showing ₹0 crore sales and ₹0 crore net profit. That is not a growth story; it is a stalled or inadequately reported one. The one positive is ROCE of 23.74%, which suggests capital deployed in the business earns a decent return. But return on equity is unavailable, book value is unavailable, debt-to-equity is unavailable, and promoter holding is unavailable. As Graham said, an investor without information is like a blind man searching for a black cat in a dark room. The Piotroski F-Score of 3 out of 9 adds to my caution. Out of nine objective tests of financial strength, Mother Nutri fails the majority. There is also no dividend yield, so as a minority shareholder I am not being paid to wait while the story is unclear. Maybe the business will turn around, but I cannot underwrite that hope with real numbers. A 28.09 P/E on zero growth and zero dividend is not a bargain; it is the opposite of a margin of safety. I am happy to wait on the sidelines until the company provides a full set of financials: actual quarterly sales, net profit, book value, leverage, and ownership data. If the future earnings power becomes visible and the price falls to a more reasonable level, then Mother Nutri can be revisited. For now, the prudent verdict is clear: too little data, too high a price, too much to assume.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer